Lünan Yan

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Philip J. Johnson, Shukui Qin, Joong‐Won Park et al. · Journal of Clinical Oncology · 2013 · 765 citations · Full text

The role of hepatic resection in the treatment of hepatocellular cancer

Sasan Roayaie, Ghalib Jibara, Parissa Tabrizian et al. · Hepatology · 2015 · 402 citations

Surgical Oncology, Gastroenterology, Multimodality +24

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Masatoshi Kudo, Guohong Han, Richard S. Finn et al. · Hepatology · 2014 · 342 citations

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

Novel techniques and preliminary results of ex vivo liver resection and autotransplantation for end-stage hepatic alveolar echinococcosis: A study of 31 cases

Xianwei Yang, Yiwen Qiu, Bin Huang et al. · American Journal of Transplantation · 2017 · 86 citations · Full text